Multiscale modeling of tumor response to vascular endothelial growth factor (VEGF) inhibitor
{{output}}
Vascular endothelial growth factor (VEGF) has been known as a key mediator of angiogenesis in cancer. Bevacizumab is anti-VEGF monoclonal antibody that has been approved by the FDA as a first-line treatment in many types of cancer. In this paper, we extend a p... ...
